Education
About Us
Working with TipRanks
Follow Us
Elevance Health, Inc. (IT:1ANTM)
:1ANTM
Total Valuation
Elevance Health has a market cap or net worth of €61.23B. The enterprise value is €104.51B.
Market Cap€61.23B
Enterprise Value€104.51B
Share Statistics
Elevance Health has 222,238,770 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding222,238,770
Owned by Insiders0.15%
Owned by Institutions2.06%
Financial Efficiency
Elevance Health’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 111.83%.
Return on Equity (ROE)0.14
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)111.83%
Return on Capital Employed (ROCE)1.51
Revenue Per Employee1.70M
Profits Per Employee57.30K
Employee Count104,200
Asset Turnover1.51
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Elevance Health is 12.4. Elevance Health’s PEG ratio is 8.48.
PE Ratio12.4
PS Ratio0.49
PB Ratio2.08
Price to Fair Value2.08
Price to FCF18.87
Price to Operating Cash Flow15.46
PEG Ratio8.48
Income Statement
In the last 12 months, Elevance Health had revenue of 176.81B and earned 5.98B in profits. Earnings per share was 25.81.
Revenue176.81B
Gross Profit176.81B
Operating Income7.90B
Pretax Income7.90B
Net Income5.98B
EBITDA10.48B
Earnings Per Share (EPS)25.81
Cash Flow
In the last 12 months, operating cash flow was 4.91B and capital expenditures -1.15B, giving a free cash flow of 3.77B billion.
Operating Cash Flow4.91B
Free Cash Flow3.77B
Free Cash Flow per Share16.95
Dividends & Yields
Elevance Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.14
52-Week Price Change-27.08%
50-Day Moving Average281.47
200-Day Moving Average323.48
Relative Strength Index (RSI)31.68
Average Volume (3m)16.00
Important Dates
Elevance Health upcoming earnings date is Jan 28, 2026, Before Open (Confirmed).
Last Earnings DateOct 21, 2025
Next Earnings DateJan 28, 2026
Ex-Dividend Date―
Financial Position
Elevance Health as a current ratio of 2.01, with Debt / Equity ratio of 2.11%
Current Ratio2.01
Quick Ratio2.01
Debt to Market Cap0.36
Net Debt to EBITDA2.19
Interest Coverage Ratio115.81
Taxes
In the past 12 months, Elevance Health has paid 1.93B in taxes.
Income Tax1.93B
Effective Tax Rate0.24
Enterprise Valuation
Elevance Health EV to EBITDA ratio is 10.38, with an EV/FCF ratio of 23.91.
EV to Sales0.62
EV to EBITDA10.38
EV to Free Cash Flow23.91
EV to Operating Cash Flow18.74
Balance Sheet
Elevance Health has €8.71B in cash and marketable securities with €929.00M in debt, giving a net cash position of €7.78B billion.
Cash & Marketable Securities€8.71B
Total Debt€929.00M
Net Cash€7.78B
Net Cash Per Share€35.03
Tangible Book Value Per Share€4.53
Margins
Gross margin is 77.66%, with operating margin of 77.62%, and net profit margin of 3.38%.
Gross Margin77.66%
Operating Margin77.62%
Pretax Margin4.47%
Net Profit Margin3.38%
EBITDA Margin5.93%
EBIT Margin5.14%
Analyst Forecast
The average price target for Elevance Health is €339.92, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€339.92
Price Target Upside23.70% Upside
Analyst ConsensusModerate Buy
Analyst Count15
Revenue Growth Forecast―
EPS Growth Forecast―